期刊文献+

补肾通络疏肝方治疗中老年男性部分雄激素缺乏症的临床研究 被引量:1

Bushentongluoshugan Formula used for treating partial hypoandrogenism
原文传递
导出
摘要 目的观察补肾通络疏肝方治疗中老年男性部分雄激素缺乏症的疗效。方法2003年2月~2005年10月男科门诊经雄激素部分缺乏问卷评分、血清总睾酮(TT)测定筛选出雄激素部分缺乏症患者69例,平均年龄61.77岁,无器质性病变。36例作为治疗组予口服补肾通络疏肝方3个月,33例作为对照组末予特殊治疗。观察比较治疗前后雄激素部分缺乏评分和性激素的变化。结果治疗组治疗3个月,雄激素部分缺乏评分总分、构成评分和TT水平与治疗前比较明显改善(P〈0.05),与对照组比较有显著性差异(P〈0.05)。对照组雄激素部分缺乏评分总分、构成评分及性激素水平无明显变化(P〉0.05)。结论补肾通络疏肝方治疗中老年男性部分雄激素缺乏症安全、有效。 Objective To observe the curative effect of Bushentongluoshugan Formula on partial hypoandrogenism (PH) in middle-aged and aged males. Methods The questionnaire score and serum total testosterone (TT) determination were used to screen 69 patients with PH ( mean age was 61.77, without organic diseases) from andrology OPD from Feb. 2002 to Oct. 2005. The patients were divided into the treatment group ( n = 36 ) given Bushentongluoshugan Formula orally for 3 months, and the control group ( n = 33 ) not given any special treatment. The changes of PH scores and sexual hormone levels were observed and compared in two groups before and after the treatment. Result The total PH score, structure score and TT level in the treatment group were improved obviously after 3 month treatment ( P 〈0.05 ) with a significant difference compared with the control group ( P 〈 0.05 ). The result in the control group was not changed (P 〉 0.05 ). Conclusion Bushentongluoshugan Formula is safe and effective for treating PH in middle-aged and aged males.
机构地区 空军总医院
出处 《北京中医药大学学报》 CAS CSCD 北大核心 2006年第12期859-861,共3页 Journal of Beijing University of Traditional Chinese Medicine
关键词 补肾通络疏肝方 中老年男性 雄激素缺乏症 Bushentongluoshugan Formula middle-aged and aged males hypoandrogenism
  • 相关文献

参考文献5

二级参考文献24

  • 1Tenover J, Feldman HA, Goldstein I, et al. Impotence and its medical and psychosocial correloles; results of Massachusetts male aging study. J Urol 1994;151:54-61. 被引量:1
  • 2Mackay DC, Harrison WJ, Bates JH, et al. Audit of deep wound infection following fracture surgery. J R Coil Surg Edinb 2000; 45(1): 56-59. 被引量:1
  • 3Roggla G, Moser B, Wagner A, et al. L-Tryptophan dose not influence acute ventilatory response at moderate altitude. Wien Klin Wochenschr 2000; 112(14): 634-636. 被引量:1
  • 4Paulsen JS, Ready RE, Hamilton JM, et al. Neuropsychiatric aspects of Huntington's disease. J Neurol Neurosurg Psychiatry 2001; 71(3): 310-314. 被引量:1
  • 5Okuda K, Okuda N, Hayama T. Hepatobiliary and pancreatic: a man with fever and hepatomegaly. J Gastroenterol Hepatol 1999; 14(11): 1135, 1139-1140. 被引量:1
  • 6Gooren LJG, The age-related decline of androgen levels in men: Clinically Significant? Br J Urol 1996; 78: 763-768. 被引量:1
  • 7Lunenfeld B, Men's health in the 21^st Century. Aging Male 2001; 4(suppl 1): 69-76. 被引量:1
  • 8Reddy DN. Testosterone replacement therapy in subjects with partial androgen deficiency in aging men (PADAM) Symptoms. Aging Male 2001; 4(1): 86. 被引量:1
  • 9Tan R.S. Testosterone and new delivery systems in the treatment of male hypogonadism in aging males.Aging Male 2001; 4(Suppl 1): 67-68. 被引量:1
  • 10Frajese GV, De mertrno MU, Calcagni E, et al, The epidemiology of partial and rogen deficiency in aging men(PADAM). J Endocrin Invest 2005; 28(3 Suppl): 3-7. 被引量:1

共引文献15

同被引文献7

引证文献1

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部